Extracellular matrix and growth factor receptors (ECM/GFR)

The target complex comprising extracellular matrix (ECM) receptors and associated growth factor receptors represents a coordinated signaling environment essential for tissue homeostasis and wound healing. This target includes a variety of proteins such as integrins and receptors for growth factors like Fibroblast Growth Factor (FGF) and Transforming Growth Factor-beta (TGF-beta), which are often sequestered and protected by endogenous heparan sulfates (Barritault et al., 2017). In pathological states like chronic ulcers or corneal erosions, the degradation of the ECM leads to the rapid proteolysis of these growth factors, stalling the healing process. Therapeutic interventions, specifically Reconstituted Glycosaminoglycan-like Agents (RGTAs), function as synthetic mimetics of heparan sulfate. These agents bind to and stabilize the ECM scaffold and the associated growth factors, protecting them from enzymatic breakdown and restoring their biological activity (PubMed, 2021). By facilitating the natural signaling pathways of multiple growth factors simultaneously, these therapies promote cell migration and tissue regeneration in environments where the endogenous matrix is compromised. This multi-target approach is primarily utilized in treating chronic skin ulcers and corneal defects where traditional single-target therapies often fail (Journal of Ophthalmology, 2018).

Other names

Multiple endogenous ECM receptors and associated growth factor receptorsECM-GF complexHeparan sulfate mimetic targetsRGTA targets

Acts as a heparan sulfate mimetic to stabilize and protect endogenous growth factors and extracellular matrix (ECM) proteins from proteolytic degradation, thereby restoring the regenerative microenvironment and promoting natural tissue repair (Barritault et al., 2017).